Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Mar 08 2025

· Issued by Oxygenta Pharmaceutical Limited

Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of SEBI (SAST) Regulations, 2011, and amendments thereto ("SEBI (SAST) Regulations, 2011") for the attention of the Public Shareholders of Oxygenta Pharmaceutical Ltd ("Target Company").

View Attachment